• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Cretex Companies CEO Steps Down

    Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread

    Endoscopic Hemostasis Devices Market Valued at $730 Million

    Henry Schein Buys Majority Interest in Prism Medical Products

    Boston Scientific's Vercise Genus DBS Earns FDA Approval
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    FUTEK Advanced Sensor Technology Inc.

    PTI Engineered Plastics Inc.

    MW Life Sciences

    Medbio LLC

    Qosina Corp.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Medicoil

    Unicep

    Spectrum Plastics Group

    Concise Engineering

    Medbio LLC
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Top30

    7. Cardinal Health

    ...

    Related CONTENT
    • Katena Products Welcomes New CEO
    • The Heart of the Matter: Trends in Cardiology
    • The Top 30 and M&A in 2021: What’s Next?
    • TransMed7 Appoints Strategic Advisor to its Board of Directors
    • Strategic Refocusing
    07.26.18
    $13.5 Billion ($130B total)

    KEY EXECUTIVES:
    Mike Kaufmann, CEO
    Jon Giacomin, CEO, Medical Segment
    Jorge M. Gomez, CFO
    Debbie Weitzman, President, U.S. Pharmaceutical Distribution
    Patrick Holt, President, Cordis
    Steve Mason, President, Cardinal Health at Home
    Steve Blazejewski, President, Global Commercial Solutions
    Craig Cowman, Exec. VP, Global Sourcing
    Joseph DePinto, President, Cardinal Health Specialty Solutions
    Michele Holcomb, Exec. VP, Strategy and Corporate Development

    NO. OF EMPLOYEES: 49,800 (total)

    GLOBAL HEADQUARTERS: Dublin, Ohio

    The rumors swirled. Many saw it unlikely that Medtronic would hold onto the Patient Care product portfolio of former MPO Top 30 company list member, Covidien—the acquisition of which was announced in June 2014 for more than $42 billion. When and to whom the business would be divested, however, was never clear. A Reuters exclusive in early April 2017 had sources claim the deal was going down between Medtronic and Cardinal Health, but nothing was officially announced at that time. Finally, all the speculation came to an end approximately two weeks later when it was made known the unit would indeed be purchased by Cardinal Health for $6.1 billion.

    The full purchase was for Medtronic’s Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses, parts of the firm’s Patient Monitoring & Recovery division of its Minimally Invasive Therapies Group. In total, the three businesses consisted of 23 product categories across multiple market settings. Brands involved in the transaction included Curity, Kendall, Dover, Argyle, and Kangaroo, most of which are used in the majority of U.S. hospitals. Combined, the divested assets accounted for approximately $2.4 billion in revenue over the prior four reported quarters for Medtronic. Now, it was joining Cardinal Health, a company whose medical device segment was dwarfed by its pharmaceutical unit by almost 10 times.

    “We are thrilled about today’s announcement, as this well-established product line is complementary to our medical consumables business and fits naturally into our customer offering. For this reason, this product portfolio has been on our radar for many years,” said George S. Barrett, then Cardinal Health chairman and CEO. “We distribute some of these products today and have been collaborative partners with the leadership of this business. Given the current trends in healthcare, including aging demographics and a focus on post-acute care, this industry-leading portfolio will help us further expand our scope in the operating room, in long-term care facilities, and in home healthcare, reaching customers across the entire continuum of care.”

    The transaction also saw almost 10,000 former Medtronic employees join Cardinal Health along with the expansive product portfolio. In incorporating the new lines into its catalog, the company saw its total product SKUs increase from nearly 12,000 in 850 categories to almost 21,000 product SKUs in 1,200 categories. The growth of the company is further illustrated when considering that only five years earlier, those numbers were closer to 4,800 SKUs in 470 categories. More specifically, the newly acquired products included incontinence, wound care, enteral feeding, urology, operating room supply, electrode and needle, syringe, and sharps disposal lines. Those offerings join Cardinal Health’s preexisting goods, including cardiovascular and endovascular products; wound care products; single-use surgical drapes, gowns, and apparel; exam and surgical gloves; and fluid suction and collection systems.

    “This is a positive transaction for all involved—Medtronic, Cardinal Health, and our respective shareholders and employees—who we believe will all thrive under this change in ownership,” Omar Ishrak, Medtronic’s chairman and CEO, declared at the time of the announcement of the deal. “Ultimately, we came to the conclusion that these products—while truly meaningful to patients in need—are best suited under ownership that can provide the investment and focus that these businesses require.”


    ANALYST INSIGHTS: Cardinal has been adept at acquisitions and divestitures over the past several years, continuing to grow their status on the performance list. As they have continued to expand globally, their market share continues to grow in an already crowded field.

    —Marissa K. Fayer, CEO and Founder, Health Equity for Women and HERHealthEQ



    The transaction wasn’t officially completed by the close of Cardinal Health’s 2017 fiscal year, but rather one month later at the end of July. It was expected at that time the integration work and transitions would be completed over the next 18 months.

    The new businesses were joining an already well-established array of products that were well known throughout hospitals, doctors’ offices, and healthcare facilities. As previously noted, while the medical segment of Cardinal Health represents a small fraction of the firm’s overall revenue, it’s still a significant presence within the medical device industry space. In its 2017 fiscal year—which ran from the first day of July 2016 to the last day of June 2017—the overall company saw $130 billion in total revenue, an increase of 7 percent over prior year. Of that, the pharmaceutical segment contributed the lion’s share at more than $116 million, which mirrored the company’s growth at 7 percent over the previous fiscal period. The medical segment, however, enjoyed near double digit growth, coming in at a 9 percent increase over 2016’s fiscal year. That translated to $13.5 billion in total revenue for the segment. Cardinal Health points to sales growth from new and existing customers as well as $212 million in contributions from acquisitions.

    Undoubtedly, the company was also looking to gain growth from new distribution deals announced throughout its 2017 fiscal year—the focus of which was on an acquisition that took place in 2015. At that time, Cardinal Health had paid almost $2 billion for Johnson & Johnson’s Cordis unit. With what seemed to be a strategic focus on a number of international regions (with a heavy emphasis on Asia), the distribution agreements primarily focused on the former J&J entity, but did include other portions of the firm’s medical segment.

    For example, in October 2016, it was announced that the company would bring powder-free gloves to Hong Kong, while further penetrating the disposable drapes and gowns segment as part of its expansion in Asia.

    “There is a tremendous demand for powder-free gloves in Asia,” said Carl Hall, vice president/managing director of Commercialization, Asia-Pacific at Cardinal Health. “In this region, aside from Japan, Australia, New Zealand, and Hong Kong, approximately 70 percent of users are still using powdered gloves. Our goal is to help Asia move to a powder-free environment in order to improve the safety and health of patients and clinicians.”


    ANALYST INSIGHTS: Almost one year after the official close of its $6.1 billion acquisition of the legacy Covidien (MDT) Patient Recovery Business (Patient care, DVT, and Nutritional Insufficiency), Cardinal Health is looking to make its next move deeper into the device world, while the jury is still out on the $150 million of assumed synergies on the Covidien purchase.

    —Mark Bonifacio, Founder and President, Bonifacio Consulting Services



    The company was also broadening its product lines within the region with a focus on single-use surgery products to enable better infection control methods. Providing a disposable option, explained Hall, gives healthcare providers a more economical, less pollutant, and safer solution that fulfills their needs.

    Later that same month, Cardinal Health announced new and expanded distribution deals involving a third party that ultimately bolstered the Cordis business offering. The agreements, which added coronary stents and percutaneous transluminal coronary angioplasty (PTCA) balloon catheters, expanded Cordis’ portfolio of products that support the treatment of patients undergoing percutaneous coronary intervention.

    Announced in conjunction with the 28th annual Transcatheter Cardiovascular Therapeutics scientific symposium of the Cardiovascular Research Foundation, details illustrate the company’s continued focus on the Asian market, but also demonstrate opportunities realized in North America, for example:
    • An expansion of an existing distribution agreement with Biosensors. The new arrangement enabled Cordis to be the exclusive distributor for Biosensors’ coronary interventional products in Japan. This put Cordis in a position to distribute Biosensors’ coronary stent portfolio in approximately 27 countries in Europe, the Middle East, and Africa (EMEA), in addition to Japan, Australia, and New Zealand (at the time of the announcement).
    • A distribution agreement was announced with Kaneka, enabling Cordis to distribute the company’s PTCA balloon catheters in EMEA, as well as select countries in Asia Pacific and Latin America (LATAM). In Japan, Korea, Australia, and New Zealand, Cordis would be able to sell versions of Kaneka’s PTCA balloon catheters under the names of NEON and NEON NC. In China, Cordis was declared to be the sole distributor of Ikazuchi Rev and Fortis II, under Kaneka’s brand. Cordis would also begin selling the Ikazuchi Zero and Raiden 3 PTCA balloons under the Kaneka brand name pending Kaneka receiving CE mark and other regulatory clearances in EMEA, China, and select LATAM countries.
    • A distribution agreement with Meril that enabled Cordis to sell Meril’s MOZEC and MOZEC NC Rx PTCA balloon dilatation catheters in the United States and Canada.
    “In the past year, since becoming a Cardinal Health company, we have executed several key strategic collaborations that strengthen the Cordis product and solutions offering in interventional cardiology,” said David Wilson, then president of Cordis. “We strongly believe that agreements like these provide the opportunity to rapidly expand our portfolio and deliver increased value to customers around the world. We will continue to explore additional opportunities to broaden the global Cordis offering.”


    ANALYST INSIGHTS: Now that the $6 billion acquisition of the Covidien portfolio (from MDT) is complete, Cardinal continues to look to growth acquisition targets that will also help its bottom line performance. Cardinal is under pressure on margins in their Pharma business and needs value-added help from new portfolio additions.

    —Dave Sheppard, Co-Founder and Principal, MedWorld Advisors



    At the end of March 2017, Cardinal Health doubled down on expanding the international market opportunity for its Cordis unit with two additional deals, both of which expanded the company’s presence in China:
    • An agreement with Brosmed that enabled Cordis to exclusively commercialize two of Brosmed’s PTCA balloon catheters in China. The deal centered around Brosmed’s Artimes, a pre-dilation semi-compliance PTCA balloon, and Apollo, a post-dilation high pressure PTCA balloon, both of which were manufactured in the Guangdong Province in China and had already obtained approval from the China Food and Drug Administration.
    • An agreement that permitted Cordis to commercialize Kaneka’s portfolio of semi- and non-compliant workhorse PTCA balloon catheters in China. The products have a low-entry profile and hydrophilic coating that facilitate access to calcified lesions or lesions that require higher crossability.
    “Cordis, as a Cardinal Health company, has significantly expanded our offerings in China during the last 12 months with several new products in interventional cardiovascular,” said Jessie Lian, general manager of Cordis China. “We are committed to ensuring Chinese patients have access to high quality cardiovascular care, from access to intervention and closure.”
    Related Searches
    • infection control
    • minimally invasive
    • ceo
    • ul
    Suggested For You
    Katena Products Welcomes New CEO Katena Products Welcomes New CEO
    The Heart of the Matter: Trends in Cardiology The Heart of the Matter: Trends in Cardiology
    The Top 30 and M&A in 2021: What’s Next? The Top 30 and M&A in 2021: What’s Next?
    TransMed7 Appoints Strategic Advisor to its Board of Directors TransMed7 Appoints Strategic Advisor to its Board of Directors
    Strategic Refocusing Strategic Refocusing
    Top 30 Global Medical Device Companies Top 30 Global Medical Device Companies
    The 2018 Top 30 Global Medical Device Companies The 2018 Top 30 Global Medical Device Companies
    1. Medtronic plc 1. Medtronic plc
    2. Johnson & Johnson 2. Johnson & Johnson
    4. Siemens Healthineers 4. Siemens Healthineers
    8. Stryker Corp. 8. Stryker Corp.
    10. Baxter International 10. Baxter International
    13. Danaher Corp. 13. Danaher Corp.
    18. 3M Health Care 18. 3M Health Care
    22. Dentsply Sirona 22. Dentsply Sirona

    Related Top30

    • The 2020 Top 30 Global Medical Device Companies

      The 2020 Top 30 Global Medical Device Companies

      Leadership changes, divestments, and portfolio-building partnerships—through acquisition or collaboration—were common threads among medtech’s largest players.
      MPO Editors 07.21.20

    • The 2019 Top 30 Global Medical Device Companies

      The 2019 Top 30 Global Medical Device Companies

      ...
      Sean Fenske, Michael Barbella, & Sam Brusco, MPO Editorial Staff 07.30.19

    • 1. Medtronic

      1. Medtronic

      ...
      07.30.19


    • 2. Johnson & Johnson

      2. Johnson & Johnson

      ...
      07.30.19

    • 3. GE Healthcare

      3. GE Healthcare

      ...
      07.30.19

    • 4. Abbott

      4. Abbott

      ...
      07.30.19


    • 5. Philips

      5. Philips

      ...
      07.30.19

    • 6. BD

      6. BD

      ...
      07.30.19

    • 7. Cardinal Health

      7. Cardinal Health

      ...
      07.30.19


    • 7. Siemens Healthineers

      7. Siemens Healthineers

      ...
      07.30.19

    • 9. Stryker

      9. Stryker

      ...
      07.30.19

    • 10. Baxter

      10. Baxter

      ...
      07.30.19


    • 11. Boston Scientific

      11. Boston Scientific

      ...
      07.30.19

    • 12. Danaher

      12. Danaher

      ...
      07.30.19

    • 13. EssilorLuxottica

      13. EssilorLuxottica

      ...
      07.30.19


    Trending
    • Telemedicine, Regulatory Changes To Characterize Medtech Industry In 2021
    • Masimo Earns CE Mark For New Fingertip Pulse Oximeter
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Philips Buys Capsule Technologies In $635M Deal
    • Understanding Food-Grade Vs. Biocompatibility For Medical Device Materials
    Breaking News
    • Cretex Companies CEO Steps Down
    • Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread
    • Endoscopic Hemostasis Devices Market Valued at $730 Million
    • Henry Schein Buys Majority Interest in Prism Medical Products
    • Boston Scientific's Vercise Genus DBS Earns FDA Approval
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet
    Gadot Positions Mineral Line for Vegan Market
    Nutritfy India to Launch Global Broadcast Channel Covering Nutrition
    Coatings World

    Latest Breaking News From Coatings World

    LINE-X Launches Dealer Program with International Truck
    PPG Reports Q4, Full-year 2020 Financial Results
    BASF Begins Implementing Ralignment of Global Business Services Unit
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cretex Companies CEO Steps Down
    Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread
    Endoscopic Hemostasis Devices Market Valued at $730 Million
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pfizer, BioNTech Enter Vax Pact with COVAX
    FDA Approves Janssen’s CABENUVA
    AGC Biologics Appoints Boulder Site GM
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Coty Appoints Chief Procurement Officer
    Lageen Tubes Launches Mono-Material PE Tube Solutions
    Jason Jones Loses Battle with Covid-19
    Happi

    Latest Breaking News From Happi

    Carol’s Daughter Adds New Hair Products
    Moroccan Gold Series Launches NuDo Shampoo
    Youbody Debuts Waterless Body Wash
    Ink World

    Latest Breaking News From Ink World

    BOBST Demonstrates Future of Flexible Packaging Production at Virtual Open House
    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    AR Packaging Acquiring Firstan Holdings Ltd
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Gallus planning virtual event for March
    Lemu Group engineers mask-making machine
    Niagara Label upgrades with Nilpeter flexo press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Freudenberg to Establish Apparel Interlining Competence Centers
    Minet Adds Spunlace Line in Romania
    Lemu Group Engineers Mask-Making Machine
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Cretex Companies CEO Steps Down
    Conformis Enters Development & Supply Agreement with SITES Medical
    Sectra, RSA Biomedical Sign Distribution Agreement for Implant Stability Tool
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Ambiq Wins IoT Semiconductor Company of the Year Award
    Ynvisible Names Michael Robinson CEO, Jani-Mikael Kuusisto SVP Ventures

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login